Table 2.
The sex-specific prevalence of MetSs of older adults with different states of liver function
| Characteristic | all | Male | Female | p-value2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overall, N = 1,014,5411 | Normal, N = 869,5081 | Abnormal, N = 145,0331 | Overall, N = 847,0491 | normal, N = 731,3231 | abnormal, N = 115,7261 | Overall, N = 167,4921 | normal, N = 138,1851 | abnormal, N = 29,3071 | ||
| BMI | 23.63 (3.12) | 23.58 (3.05) | 23.93 (3.48) | 23.59 (3.07) | 23.55 (3.01) | 23.81 (3.42) | 23.84 (3.36) | 23.72 (3.29) | 24.40 (3.65) | < 0.001 |
| WC | 84.60 (9.04) | 84.45 (8.90) | 85.54 (9.80) | 84.84 (8.98) | 84.71 (8.84) | 85.72 (9.78) | 83.38 (9.23) | 83.08 (9.07) | 84.84 (9.85) | < 0.001 |
| SBP | 139.32 (17.90) | 139.14 (17.87) | 140.37 (18.05) |
139.04 (17.80) |
138.87 (17.76) |
140.15 (17.99) |
140.70 (18.34) | 140.59 (18.35) | 141.22 (18.26) | < 0.001 |
| DBP | 80.36 (10.12) |
80.25 (10.08) |
81.04 (10.31) |
80.59 (10.12) | 80.46 (10.08) | 81.35 (10.33) | 79.24 (10.04) | 79.12 (10.02) |
79.79 (10.11) |
< 0.001 |
| FBG |
5.60 (5.00, 6.20) |
5.50 (5.00, 6.10) |
5.70 (5.00, 6.58) |
5.51 (5.00, 6.20) |
5.50 (5.00, 6.10) |
5.70 (5.00, 6.50) |
5.70 (5.02, 6.20) |
5.60 (5.00, 6.15) |
5.90 (5.10, 6.70) |
< 0.001 |
| TG |
1.30 (0.98, 2.00) |
1.30 (0.96, 2.00) |
1.54 (1.00, 2.21) |
1.28 (0.93, 2.00) |
1.24 (0.91, 1.99) |
1.50 (1.00, 2.22) |
1.54 (1.02, 2.00) |
1.50 (1.00, 2.00) |
1.70 (1.10, 2.20) |
< 0.001 |
| HDL-C |
1.49 (1.20, 1.93) |
1.49 (1.20, 1.91) |
1.53 (1.21, 2.00) |
1.47 (1.19, 1.89) |
1.46 (1.19, 1.87) |
1.51 (1.20, 2.00) |
1.60 (1.29, 2.00) |
1.60 (1.30, 2.00) |
1.59 (1.27, 2.00) |
< 0.001 |
| BMI ≥ 24 or WC ≥ 80 cm(M) 85(F) | 490,906 (48.39%) | 414,519 (47.67%) | 76,387 (52.67%) | 398,784 (47.08%) | 340,522 (46.56%) | 58,262 (50.34%) | 92,122 (55%) | 73,997 (53.55%) | 18,125 (61.85%) | < 0.001 |
| BP ≥ 140/90 mmHg | 553,412 (54.55%) | 470,383 (54.10%) | 83,029 (57.25%) | 457,753 (54.04%) | 391,850 (53.58%) | 65,903 (56.95%) | 95,659 (57.11%) | 78,533 (56.83%) | 17,126 (58.44%) | < 0.001 |
| FBG ≥ 5.6 mmol/L | 507,746 (50.05%) | 427,483 (49.16%) | 80,263 (55.34%) | 417,524 (49.29%) | 354,713 (48.50%) | 62,811 (54.28%) | 90,222 (53.87%) | 72,770 (52.66%) | 17,452 (59.55%) | < 0.001 |
| TG ≥ 1.70 mmol/L | 361,262 (35.61%) | 295,266 (33.96%) | 65,996 (45.50%) | 286,355 (33.81%) | 235,016 (32.14%) | 51,339 (44.36%) | 74,907 (44.72%) | 60,250 (43.60%) | 14,657 (50.01%) | < 0.001 |
| HDL-C ≤ 1.0(M) 1.3(F) | 139,055 (13.71%) | 117,113 (13.47%) | 21,942 (15.13%) | 94,873 (11.20%) | 81,076 (11.09%) | 13,797 (11.92%) | 44,182 (26.38%) | 36,037 (26.08%) | 8,145 (27.79%) | < 0.001 |
| Number of Metabolic Syndromes | < 0.001 | |||||||||
| 0 | 116,286 (11.46%) | 103,348 (11.89%) | 12,938 (8.92%) | 104,864 (12.38%) | 93,518 (12.79%) | 11,346 (9.80%) | 11,422 (6.82%) | 9,830 (7.11%) | 1,592 (5.43%) | |
| 1 | 252,950 (24.93%) | 222,364 (25.57%) | 30,586 (21.09%) | 220,762 (26.06%) | 194,881 (26.65%) | 25,881 (22.36%) | 32,188 (19.22%) | 27,483 (19.89%) | 4,705 (16.05%) | |
| 2 | 288,990 (28.48%) | 250,442 (28.80%) | 38,548 (26.58%) | 242,423 (28.62%) | 211,253 (28.89%) | 31,170 (26.93%) | 46,567 (27.80%) | 39,189 (28.36%) | 7,378 (25.17%) | |
| 3 | 225,120 (22.19%) | 188,560 (21.69%) | 36,560 (25.21%) | 180,958 (21.36%) | 152,601 (20.87%) | 28,357 (24.50%) | 44,162 (26.37%) | 35,959 (26.02%) | 8,203 (27.99%) | |
| 4 | 109,884 (10.83%) | 88,134 (10.14%) | 21,750 (15.00%) | 83,403 (9.85%) | 67,363 (9.21%) | 16,040 (13.86%) | 26,481 (15.81%) | 20,771 (15.03%) | 5,710 (19.48%) | |
| 5 | 21,311 (2.10%) | 16,660 (1.92%) | 4,651 (3.21%) | 14,639 (1.73%) | 11,707 (1.60%) | 2,932 (2.53%) | 6,672 (3.98%) | 4,953 (3.58%) | 1,719 (5.87%) | |
BMI = body mass index; WC = waist circumference; SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = fasting blood glucose;TG = triglycerides; HDL-C = high-density lipoprotein cholesterol
1Mean (SD); Median (IQR); n (%)
2Pearson's Chi-squared test; Kruskal–Wallis rank sum test